IL-1-话题@MedSci

#IL-1#

184篇内容 | 4464人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1508253, encodeId=0df2150825386, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Scand J Immunol：过敏性鼻炎患者中PD-1/PD-L1途径的阻断能够促进CD19+ CD25+ Bregs细胞凋亡和抑制IL-10的分泌, objectType=article, longId=181815, objectId=99801818158b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99801818158b, replyNumber=0, likeNumber=81, createdTime=2019-10-23, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99801818158b, moduleTitle=Scand J Immunol：过敏性鼻炎患者中PD-1/PD-L1途径的阻断能够促进CD19+ CD25+ Bregs细胞凋亡和抑制IL-10的分泌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99801818158b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508252, encodeId=3e731508252ef, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Clinica Chimica Acta：循环IL-17水平升高与炎症性关节炎和疾病活动相关, objectType=article, longId=181555, objectId=d23e181555b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d23e181555b5, replyNumber=0, likeNumber=83, createdTime=2019-10-20, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d23e181555b5, moduleTitle=Clinica Chimica Acta：循环IL-17水平升高与炎症性关节炎和疾病活动相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d23e181555b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508251, encodeId=cc6d1508251bc, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=诺华的IL-17A单抗Cosentyx治疗非放射线轴性脊柱关节炎的III期临床成功, objectType=article, longId=180601, objectId=697618060195, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=697618060195, replyNumber=0, likeNumber=49, createdTime=2019-10-08, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=697618060195, moduleTitle=诺华的IL-17A单抗Cosentyx治疗非放射线轴性脊柱关节炎的III期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=697618060195)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508250, encodeId=b137150825003, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=头对头牛皮癣研究中，礼来的IL-17A单抗Taltz与强生的IL-23单抗Tremfya相比可提高皮肤清除率, objectType=article, longId=180571, objectId=711e1805e121, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=711e1805e121, replyNumber=0, likeNumber=38, createdTime=2019-10-07, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=711e1805e121, moduleTitle=头对头牛皮癣研究中，礼来的IL-17A单抗Taltz与强生的IL-23单抗Tremfya相比可提高皮肤清除率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=711e1805e121)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508249, encodeId=9a0d150824902, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=GUT： IBD中的抗TNF治疗是通过巨噬细胞IL-10信号发挥其治疗作用的, objectType=article, longId=180541, objectId=185e180541fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=185e180541fd, replyNumber=0, likeNumber=70, createdTime=2019-10-07, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=185e180541fd, moduleTitle=GUT： IBD中的抗TNF治疗是通过巨噬细胞IL-10信号发挥其治疗作用的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=185e180541fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508248, encodeId=d0d215082481e, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Sci transl med：IL-11可作为肺纤维化的治疗靶点！, objectType=article, longId=180125, objectId=97ac1801254d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97ac1801254d, replyNumber=0, likeNumber=72, createdTime=2019-09-28, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97ac1801254d, moduleTitle=Sci transl med：IL-11可作为肺纤维化的治疗靶点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97ac1801254d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508247, encodeId=3578150824eda, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Clinica Chimica Acta：代谢综合征患者IL-10与冠心病严重程度的关系, objectType=article, longId=179876, objectId=16a11e987639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16a11e987639, replyNumber=0, likeNumber=62, createdTime=2019-09-24, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16a11e987639, moduleTitle=Clinica Chimica Acta：代谢综合征患者IL-10与冠心病严重程度的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16a11e987639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508246, encodeId=675515082467e, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=礼来的IL-17A单抗Taltz获得FDA批准扩展用于活动性强直性脊柱炎, objectType=article, longId=178241, objectId=2a911e824102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a911e824102, replyNumber=0, likeNumber=105, createdTime=2019-08-29, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a911e824102, moduleTitle=礼来的IL-17A单抗Taltz获得FDA批准扩展用于活动性强直性脊柱炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a911e824102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508245, encodeId=5a1a150824526, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Sci transl med：IL-12基因疗法治疗复发性高级别胶质瘤的安全性和疗效, objectType=article, longId=178017, objectId=010a1e801749, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=010a1e801749, replyNumber=0, likeNumber=65, createdTime=2019-08-22, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=010a1e801749, moduleTitle=Sci transl med：IL-12基因疗法治疗复发性高级别胶质瘤的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=010a1e801749)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508244, encodeId=67491508244d6, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Lancet发表III期ECLIPSE研究，证明IL-23单抗TREMFYA比IL-17单抗COSENTYX治疗中度至重度银屑病具有更好的长期疗效, objectType=article, longId=177388, objectId=8ab51e73889d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ab51e73889d, replyNumber=0, likeNumber=34, createdTime=2019-08-12, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ab51e73889d, moduleTitle=Lancet发表III期ECLIPSE研究，证明IL-23单抗TREMFYA比IL-17单抗COSENTYX治疗中度至重度银屑病具有更好的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ab51e73889d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508243, encodeId=d3a715082431e, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=J Immunol：IL-11在多发性硬化症和自身免疫性脑脊髓炎中诱导脑炎性Th17细胞, objectType=article, longId=176318, objectId=a36e1e6318f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a36e1e6318f6, replyNumber=0, likeNumber=80, createdTime=2019-07-29, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a36e1e6318f6, moduleTitle=J Immunol：IL-11在多发性硬化症和自身免疫性脑脊髓炎中诱导脑炎性Th17细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a36e1e6318f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508242, encodeId=18fe1508242bd, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=FDA批准将赛诺菲/再生元的IL-4/IL-13单抗Dupixent用于治疗鼻息肉, objectType=article, longId=174393, objectId=fc561e4393b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc561e4393b5, replyNumber=0, likeNumber=81, createdTime=2019-06-29, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc561e4393b5, moduleTitle=FDA批准将赛诺菲/再生元的IL-4/IL-13单抗Dupixent用于治疗鼻息肉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc561e4393b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508241, encodeId=4d5e1508241c1, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=诺华的IL-17A单抗Cosentyx显著改善斑块状银屑病疾病症状, objectType=article, longId=173291, objectId=9eb91e32918d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9eb91e32918d, replyNumber=0, likeNumber=79, createdTime=2019-06-28, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9eb91e32918d, moduleTitle=诺华的IL-17A单抗Cosentyx显著改善斑块状银屑病疾病症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9eb91e32918d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508240, encodeId=de5c15082407f, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=赛诺菲/Regeneron的IL-13单抗REGN3500治疗哮喘II期临床试验成功, objectType=article, longId=172193, objectId=f8e41e2193df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8e41e2193df, replyNumber=0, likeNumber=56, createdTime=2019-06-27, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8e41e2193df, moduleTitle=赛诺菲/Regeneron的IL-13单抗REGN3500治疗哮喘II期临床试验成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8e41e2193df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508239, encodeId=1b20150823933, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Clin Oral Investig：中国非吸烟人群TNF-α，IL-1A和IL-1B基因多态性与种植体周围炎的相关性分析, objectType=article, longId=168547, objectId=d21216854ea5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d21216854ea5, replyNumber=0, likeNumber=69, createdTime=2019-06-17, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d21216854ea5, moduleTitle=Clin Oral Investig：中国非吸烟人群TNF-α，IL-1A和IL-1B基因多态性与种植体周围炎的相关性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d21216854ea5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508238, encodeId=7025150823823, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Hum Cell：ADRB2能够抑制miR-15a-5p调控的IL-13诱导的过敏性鼻炎炎症细胞因子, objectType=article, longId=166858, objectId=e1ed1668584f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1ed1668584f, replyNumber=0, likeNumber=0, createdTime=2019-05-27, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1ed1668584f, moduleTitle=Hum Cell：ADRB2能够抑制miR-15a-5p调控的IL-13诱导的过敏性鼻炎炎症细胞因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1ed1668584f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508237, encodeId=3e10150823ea5, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Arthritis Rheumatol：乌司奴单抗降低银屑病关节炎血清CRP、IL-17A和IL-17F水平, objectType=article, longId=166550, objectId=e11f166550e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e11f166550e5, replyNumber=0, likeNumber=95, createdTime=2019-05-23, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e11f166550e5, moduleTitle=Arthritis Rheumatol：乌司奴单抗降低银屑病关节炎血清CRP、IL-17A和IL-17F水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e11f166550e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508236, encodeId=e36d150823667, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=礼来的IL-17A单抗Taltz治疗非放射性轴向脊柱关节炎，III期临床试验大获成功, objectType=article, longId=164909, objectId=f4ff16490983, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4ff16490983, replyNumber=0, likeNumber=56, createdTime=2019-04-25, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4ff16490983, moduleTitle=礼来的IL-17A单抗Taltz治疗非放射性轴向脊柱关节炎，III期临床试验大获成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4ff16490983)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508235, encodeId=f399150823582, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市, objectType=article, longId=163639, objectId=30a2163639f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30a2163639f7, replyNumber=0, likeNumber=91, createdTime=2019-04-06, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30a2163639f7, moduleTitle=诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30a2163639f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508234, encodeId=8a471508234bf, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=JACC：IL-1β对急性失代偿心衰患者预后的预测价值, objectType=article, longId=162644, objectId=0b7d162644d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b7d162644d8, replyNumber=0, likeNumber=102, createdTime=2019-03-22, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b7d162644d8, moduleTitle=JACC：IL-1β对急性失代偿心衰患者预后的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b7d162644d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IL-1

2020-05-29

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Scand J Immunol：过敏性鼻炎患者中PD-1/PD-L1途径的阻断能够促进CD19+ CD25+ Bregs细胞凋亡和抑制IL-10的分泌

2019-10-23

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Clinica Chimica Acta：循环IL-17水平升高与炎症性关节炎和疾病活动相关

2019-10-20

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

诺华的IL-17A单抗Cosentyx治疗非放射线轴性脊柱关节炎的III期临床成功

2019-10-08

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

头对头牛皮癣研究中，礼来的IL-17A单抗Taltz与强生的IL-23单抗Tremfya相比可提高皮肤清除率

2019-10-07

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

GUT： IBD中的抗TNF治疗是通过巨噬细胞IL-10信号发挥其治疗作用的

2019-10-07

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Sci transl med：IL-11可作为肺纤维化的治疗靶点！

2019-09-28

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Clinica Chimica Acta：代谢综合征患者IL-10与冠心病严重程度的关系

2019-09-24

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

礼来的IL-17A单抗Taltz获得FDA批准扩展用于活动性强直性脊柱炎

2019-08-29

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Sci transl med：IL-12基因疗法治疗复发性高级别胶质瘤的安全性和疗效

2019-08-22

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Lancet发表III期ECLIPSE研究，证明IL-23单抗TREMFYA比IL-17单抗COSENTYX治疗中度至重度银屑病具有更好的长期疗效

2019-08-12

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

J Immunol：IL-11在多发性硬化症和自身免疫性脑脊髓炎中诱导脑炎性Th17细胞

2019-07-29

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

FDA批准将赛诺菲/再生元的IL-4/IL-13单抗Dupixent用于治疗鼻息肉

2019-06-29

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

诺华的IL-17A单抗Cosentyx显著改善斑块状银屑病疾病症状

2019-06-28

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

赛诺菲/Regeneron的IL-13单抗REGN3500治疗哮喘II期临床试验成功

2019-06-27

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Clin Oral Investig：中国非吸烟人群TNF-α，IL-1A和IL-1B基因多态性与种植体周围炎的相关性分析

2019-06-17

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Hum Cell：ADRB2能够抑制miR-15a-5p调控的IL-13诱导的过敏性鼻炎炎症细胞因子

2019-05-27

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Arthritis Rheumatol：乌司奴单抗降低银屑病关节炎血清CRP、IL-17A和IL-17F水平

2019-05-23

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

礼来的IL-17A单抗Taltz治疗非放射性轴向脊柱关节炎，III期临床试验大获成功

2019-04-25

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市

2019-04-06

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

JACC：IL-1β对急性失代偿心衰患者预后的预测价值

2019-03-22

科室
- - 订阅+
  - 更多科室
工具
服务